XTNT
Xtant Medical Holdings Inc
AMEX: XTNT · HEALTHCARE · MEDICAL DEVICES
$0.52
-0.91% today
Updated 2026-06-05
Market cap
$62.91M
P/E ratio
44.85
P/S ratio
0.52x
EPS (TTM)
$0.01
Dividend yield
—
52W range
$0 – $1
Volume
0.2M
WallStSmart proprietary scores
42
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+7.0
Quality
B+3.5
Profitability
D6.0
Valuation
B6/9
Piotroski F-Score
Moderate
-0.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$1.23
+135.71%
12-Month target
$0.30
-42.65%
Intrinsic (DCF)
$1.58
Margin of safety
+62.59%
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ 62.59% below intrinsic value
+ Debt/equity 0.32x — low leverage
Risks
- Altman Z -0.66 — distress zone
- Thin margins at 1.50%
- Negative free cash flow $-2.31M
- Revenue declining -36.50% QoQ
- P/E 44.85x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $57.97M | $91.30M | $117.27M | $133.93M | $121.91M |
| Net income | $-8.48M | $660000.00 | $-16.45M | $4.97M | $-3.09M |
| EPS | — | — | — | — | $0.01 |
| Free cash flow | $-7.11M | $-10.97M | $-16.01M | $10.16M | $-2.31M |
| Profit margin | -14.64% | 0.72% | -14.03% | 3.71% | 1.50% |
Peer comparison
Smart narrative
Xtant Medical Holdings Inc trades at $0.52. representing a P/E of 44.85x trailing earnings. Our Smart Value Score of 42/100 indicates the stock is fair. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of -0.66, it sits in the distress. TTM revenue stands at $121.91M. with profit margins at 1.50%. Our DCF model estimates intrinsic value at $1.58.
Frequently asked questions
What is Xtant Medical Holdings Inc's stock price?
Xtant Medical Holdings Inc (XTNT) trades at $0.52, on a P/E of 44.9x and a P/S of 0.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Xtant Medical Holdings Inc overvalued?
Xtant Medical Holdings Inc carries a Smart Value Score of 42/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $1.58 versus the $0.52 price, a 62.6% margin of safety on a cash flow basis.
What is the price target of Xtant Medical Holdings Inc (XTNT)?
The 12-month analyst consensus target is $1.23, about 135.7% above the current $0.52. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of Xtant Medical Holdings Inc (XTNT)?
Our DCF model estimates intrinsic value at $1.58, a +62.6% margin of safety versus today's $0.52. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is Xtant Medical Holdings Inc's revenue?
Xtant Medical Holdings Inc's trailing twelve-month revenue is $121.91M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Xtant Medical Holdings Inc's Altman Z-Score is -0.66, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeAMEX
CurrencyUSD
Quick metrics
P/S ratio0.52x
ROE3.95%
Beta-0.17
50D MA$0.50
200D MA$0.63
Shares out0.14B
Float0.05B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—